本页面由Tiger Trade Technology Pte. Ltd.提供服务

IRulya Therapeutics

32.40
+0.67002.11%
盘后:30.70-1.7000-5.25%17:35 EDT
成交量:7.69万
成交额:225.62万
市值:3,295.40万
市盈率:-0.36
高:32.61
开:29.51
低:26.50
收:31.73
52周最高:909.98
52周最低:15.10
股本:101.71万
流通股本:67.97万
量比:1.65
换手率:11.31%
股息:- -
股息率:- -
每股收益(TTM):-90.9250
每股收益(LYR):-335.2669
净资产收益率:--
总资产收益率:--
市净率:--
市盈率(LYR):-0.10

数据加载中...

公司资料

公司名字:
IRulya Therapeutics
交易所:
NASDAQ
成立时间:
2012
员工人数:
38
公司地址:
611 Gateway Boulevard,Suite 273,South San Francisco,California,United States
邮编:
94080
电话:
传真:
- -
简介:
Quince Therapeutics, Inc.于2012年6月20日在特拉华州注册成立。该公司是一家生物技术公司,在完成其3期NEAT试验之前,专注于利用其专有的AIDE技术平台开发罕见病治疗方法。

董事

名称
职位
Dirk Thye
Chief Executive Officer and Chief Medical Officer and Director
Brigette Roberts
Chief of Corporate Affairs and Director
David A. Lamond
Chairperson of the Board and Director
Christopher J. Senner
Director
June Bray
Director

股东

名称
职位
Dirk Thye
Chief Executive Officer and Chief Medical Officer and Director
Brendan Hannah
Chief Business Officer and Chief Compliance Officer and Chief Operating Officer
Brigette Roberts
Chief of Corporate Affairs and Director
Charles Ryan
President